3rd Quarter - Report
INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH for INTERNATIONAL SOCIETY FOR STEM CELL RESEARCH
Income
—
Expenses
$50,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
- Regulation of stem cell-based products as biologics. - The use of fetal tissue and chimeras in biomedical research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC D ANTHONY | — |
| MEGAN DONOVAN New | — |
Budget/Appropriations BUD
Funding for biomedical research.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC D ANTHONY | — |
| MEGAN DONOVAN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.